Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01921686 · ClinicalTrials.gov registry record

Morphological Markers of Gastroesophageal Reflux Disease (GERD)

A clinical trial of Eosinophilic Esophagitis and Gastroesophageal Reflux Disease, sponsored by Baylor College of Medicine.

Active
Registry status
54
Enrollment target
1
Study location

NCT01921686 is a study of Eosinophilic Esophagitis and Gastroesophageal Reflux Disease that is active but no longer recruiting, run by Baylor College of Medicine. The registered enrollment target is 54 participants, below the 863-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01921686, a study of Eosinophilic Esophagitis and Gastroesophageal Reflux Disease, is active but no longer recruiting, sponsored by Baylor College of Medicine.

ACTIVE NOT RECRUITING
Registry status
54 participants
Enrollment target
1
Study location

Study Summary

The purpose of this project is to learn more about a new and promising way to diagnose acid reflux disease using a very high-powered microscope. This special microscope provides much finer detail than typical microscopes previously used for diagnosing reflux, and may help doctors to better identify children with acid reflux.

Interventions

  • OTHER Sample collection and Questionnaire

Study Locations (1)

Texas

  • Texas Children's Hospital - Houston

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2013-03
Est. Completion 2026-12

Sponsor

Baylor College of Medicine

616 total trials

What the Registry Record Tells You About NCT01921686

The ClinicalTrials.gov registry entry for NCT01921686 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 863-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (94% lower). The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Eosinophilic Esophagitis appearing as the primary indexed condition, and to 1 intervention - of which Sample collection and Questionnaire is the first listed.

NCT01921686 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT01921686 about?

NCT01921686 is a clinical study titled "Morphological Markers of Gastroesophageal Reflux Disease (GERD)". The purpose of this project is to learn more about a new and promising way to diagnose acid reflux disease using a very high-powered microscope. This special microscope provides much finer detail than typical microscopes previously used for diagnosing reflux, and may help doctors to better identify ...

What is the current status of trial NCT01921686?

This trial is currently active not recruiting. The enrollment target is 54 participants. The study started on 2013-03. Estimated completion is 2026-12.

What conditions does trial NCT01921686 study?

This clinical trial studies the following conditions: Eosinophilic Esophagitis, Gastroesophageal Reflux Disease.

What interventions are being tested in trial NCT01921686?

The interventions under investigation include: Sample collection and Questionnaire (OTHER).

Who is sponsoring clinical trial NCT01921686?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01921686 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Eosinophilic Esophagitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.